The key word is "temporary." If you are in the 70 to 80% whose symptoms resolve within weeks, a brief period of discomfort may be a reasonable trade-off
TimmersLHenriquesJPde KleijnDPDevriesJHKempermanHSteendijkPet alExenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury
Nutritional deficiencies can develop when appetite suppression leads to inadequate intake of essential nutrients
Key safety observations from Phase 2 data include: Gastrointestinal side effects were the most commonly reported adverse events Dose-dependent tolerability issues were noted, particularly at higher doses, with meaningful discontinuation rates Increases in heart rate were observed, consistent with the known class effect of GLP-1 receptor agonists
Treatments Average 1015% body weight loss in 6 months1 1Hankosky ER, Chinthammit C, Meeks A, Huang A, Ward JM, Mojdami D, Gibble TH